Objectives: To compare bipolar vaporization of prostate (BPVP) with photoselective vaporization (PVP) of prostate in the surgical management of benign prostatic hyperplasia in terms of safety, efficacy and cost effectiveness. Methods: Data was analyzed retrospectively for patients who underwent either PVP or BPVP between August 2012 to July 2014 for prostate size ≤ 80 ml. Preoperative and postoperative period values along with details like operative time, blood loss, hospitalization days, catheter removal time, blood transfusion and etc., were noted down. International prostatic symptom score, quality of life scores, post void residue, and maximum flow rate were recorded preoperatively and postoperatively at each follow-up visit. Follow-up was performed at 1, 3, 6 ,12 and 18 months. Results: Similar preoperative characteristics were observed in all the study arms. Hemoglobin drop, transfusion rate, catheter time and hospital days were similar in both the groups. The follow-up data indicates sustainable significant improvement in international prostatic symptom score, quality of life, post void residue and maximum flow rate in both the groups. As expected the cost of the procedure was significantly more in PVP group as compared to BPVP group (p < 0.01). Neither group had severe perioperative complications and no blood transfusion was required in both the groups. Conclusion: Both PVP and BPVP were safe and effective alternatives in men requiring surgery for benign prostatic hyperplasia including patients who were on anticoagulants. Additionally, BPVP has the advantage of being significantly cheaper and therefore it can be more useful in developing countries.

Keywords:
Bipolar vaporization, Photoselective vaporization, Benign prostatic hyperplasia, Cost effective
1.
Mohanty NK, Vasudeva P, Kumar A, Prakash S, Jain M, Arora RP: Photoselective vaporization of prostate vs. transurethral resection of prostate: a prospective, randomized study with one year follow-up. Indian J Urol 2012; 28:307-312.
2.
Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A: Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007;51:1031-1041.
3.
Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Müller A, Lehmann K, Sulser T: Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-971.
4.
Oelke M, Alivizatos G, Emberton M, Gravas S, Madersbacher S, Michel M, Nordling J, Rioja Sanz C, de la Rosette J: Guidelines on benign prostatic hyperplasia; in Parsons KF, Irani J, Chapple CR, Fall M, Hanus T, Llorente Abarca C, Loch T, Mitropoulos D, N'Dow J, Schmid HP, Sylvester R (eds): European Association of Urology Pocket Guidelines. Arnhem: European Association of Urology, 2009, pp90-97.
5.
Geavlete B, Multescu R, Dragutescu M, Jecu M, Georgescu D, Geavlete P: Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: ‘the better choice' in benign prostatic hyperplasia? BJU Int 2010;106:1695- 1699.
6.
Geavlete B, Georgescu D, Multescu R, Stanescu F, Jecu M, Geavlete P: Bipolar plasma vaporization vs monopolar and bipolar TURP - a prospective, randomized, long-term comparison. Urology 2011;78:930-935.
7.
Zhang SY, Hu H, Zhang XP, Wang D, Xu KX, Na YQ, Huang XB, Wang XF: Efficacy and safety of bipolar plasma vaporization of the prostate with ‘button-type' electrode compared with transurethral resection of prostate for benign prostatic hyperplasia. Chin Med J (Engl) 2012;125:3811-3814.
8.
Herrmann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS: EAU guidelines on laser technologies. Eur Urol 2012;61:783- 795.
9.
Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S: A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction:an update. Eur Urol 2015; 67:1066-1096.
10.
Teng J, Zhang D, Li Y, Yin L, Wang K, Cui X, Xu D: Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int 2012;111:312-323.
11.
Capitan C, Blazquez C, Martin MD, Hernández V, de la Peña E, Llorente C: Green-Light HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011;60:734-739.
12.
Al-Ansari A, Younes N, Sampige VP, Al-Ru-maihi K, Ghafouri A, Gul T, Shokeir AA: GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm followup. Eur Urol 2010;58:349-355.
13.
Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P, De la Taille A, Lemaire P, Baron JC, Cornu JN, Aout M, Rousseau H, Vicaut E: Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 2012;61:1165- 1173.
14.
Robert G, de la Taille A, Herrmann T: Bipolar plasma vaporization of the prostate: ready to replace GreenLight? A systematic review of randomized control trials. World J Urol 2015; 33:549-554.
15.
da Silva RD, Bidikov L, Michaels W, Gustafson D, Molina WR, Kim FJ: Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol 2015;22(Suppl 1):30-44.
16.
Hon NH, Brathwaite D, Hussain Z, Ghiblawi S, Brace H, Hayne D, Coppinger SW: A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup. J Urol 2006; 176:205-209.
17.
Kranzbühler B, Wettstein MS, Fankhauser CD, Grossmann NC, Gross O, Poyet C, Largo R, Fischer B, Zimmermann M, Sulser T, Müller A, Hermanns T: Pure bipolar plasma vaporization of the prostate: the Zurich experience. J Endourol 2013;27:1261-1266.
18.
Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T: High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-160.
19.
Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE: Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-1198.
20.
Pawan V, Anop K, Niraj K, Biswajit N, Punita R, Rajendra A, Nayan M: Safety and efficacy of photoselective vaporization of prostate in patients receiving anticoagulants. Minerva Urol Nephrol 2013;65:189-195.
21.
Delongchamps NB, Robert G, de la Taille A, Haillot O, Ballereau C, Saussine C, Kleinclauss F, Azzouzi AR, Lukacs B, Dumonceau O, Fourmarier M, Devonec M, Descazeaud A: Surgical management of BPH in patients on oral anticoagulation: transurethral bipolar plasma vaporization in saline versus transurethral monopolar resection of the prostate. Can J Urol 2011;18:6007-6012.
22.
Huang X, Wang XH, Wang HP, Qu LJ: Comparison of the microvessel diameter of hyperplastic prostate and the coagulation depth achieved with mono- and bipolar transurethral resection of the prostate. A pilot study on hemostatic capability. Scand J Urol Nephrol 2008;42:265-268.
23.
Huang X, Wang L, Shi HB, Zhang XJ, Yu ZY: Bipolar transurethral resection of prostate causes deeper coagulation depth and less bleeding than monopolar transurethral prostatectomy. Urology 2012;80:1116-1120.
24.
Geavlete B, Stanescu F, Moldoveanu C, Geavlete P: Continuous vs conventional bipolar plasma vaporisation of the prostate and standard monopolar resection: a prospective, randomised comparison of a new technological advance. BJU Int 2014;113:288-295.
25.
Stovsky MD, Griffiths RI, Duff SB: A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol 2006;176(4 Pt 1):1500-1506.
26.
Alivizatos G, Skolarikos A: Photoselective vaporization of the prostate. Review of cost implementation to BPH treatment. Prostate Can Prostatic Dis 2007;10:S15-S20.
27.
Thangasamy IA, Chalasani V, Bachmann A, Woo HH: Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012;62:315-323.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.